Vitamin D and fish oil (aka omega-3 fatty acids) were the most widely used vitamin and nutritional supplement in 2011-2012. Both have been commonly touted for their potential benefits in reducing cancer and cardiovascular disease. While vitamin D and omega-3 fatty acid supplements are wildly popular, the evidence supporting their health benefits is inconclusive and inconsistent. The VITAL study sought to determine whether vitamin D and/or marine omega-3 fatty acids can prevent cardiovascular disease (CVD) and cancer when used by the general population.
Guest Authors: Anthony M Todd, PharmD; Sean E Smithgall, PharmD, BCACP; and Nicole A Slater, PharmD, BCACP
Music by Good Talk
SDOH Matters Too! Patient and Care Team Perspectives on Screening for SDOH
Treating Depression and Anxiety: Dosing, Pharmacogenetics, and Our Learners
Complex Patient Case 4: Diabetes, CKD, and Psoriasis
Can Losing Weight Using Semaglutide Prevent a Heart Attack, Ack, Ack, Ack, Ack?
Prescription for Savings: The Clinical and Economic Impact of Pharmacist-Led Hypertension Management in the U.S.
Heartburn Headache: Cumulative PPI Use and Dementia Risk
Does Size Matter? The Surprising Impact of Cuff Size on Blood Pressure Readings
Defining the Role of Semaglutide in Obese Patients with Heart Failure with Preserved Ejection Fraction
Do Statins “REPRIEVE” People Living with HIV from CV Events?
Top Ten Things Every Clinician Should Know About the RSV Vaccines
Complex Patient Case 3: Treatment Resistant Hypertension
Should We Be Good SPORTs About Supplements for Cholesterol?
Is Telehealth the Hidden (Hyper)Link to Controlling Blood Pressure?
Personalized Pharmacotherapy for Hypertension: Examining Intra-patient Variability
Over-the-Counter Hearing Aids – Where Do They Fit?
Road to Recovery: Pharmacist-Delivered Comprehensive Medication Management in an SUD Clinic
Gender Affirming Care - Finding the Resources You Need
Water Wars: Dueling Diuretics - Chlorthalidone vs. Hydrochlorothiazide for Cardiovascular Event Reduction
Beyond Statins: Approaches to Lipid Lowering in 2023
Fixed Dose or Treat-to-Target: Does LODESTAR Guide Us on Statin Management?
Create your
podcast in
minutes
It is Free
The Relaxback UK Show
Good Nurse Bad Nurse
On Call With Dr. Anselm Anyoha
The Peter Attia Drive
The Doctor’s Farmacy with Mark Hyman, M.D.